Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
6(40%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_1
8
53%
Ph phase_3
3
20%
Ph phase_2
4
27%

Phase Distribution

8

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
8(53.3%)
Phase 2Efficacy & side effects
4(26.7%)
Phase 3Large-scale testing
3(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

15

all time

Status Distribution
Active(6)
Completed(9)

Detailed Status

Completed9
Active, not recruiting3
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
15
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 18 (53.3%)
Phase 24 (26.7%)
Phase 33 (20.0%)

Trials by Status

active_not_recruiting320%
completed960%
recruiting320%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07000136Phase 3

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

Active Not Recruiting
NCT07423598Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

Active Not Recruiting
NCT06834932Phase 2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

Recruiting
NCT07000357Phase 3

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Recruiting
NCT07218900Phase 2

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

Recruiting
NCT06692764Phase 2

A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Completed
NCT07000123Phase 3

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Active Not Recruiting
NCT07216131Phase 1

A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years

Completed
NCT06173570Phase 2

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Completed
NCT06742853Phase 1

A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

Completed
NCT05787002Phase 1

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

Completed
NCT06671405Phase 1

An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

Completed
NCT06592482Phase 1

A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

Completed
NCT06576765Phase 1

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

Completed
NCT05384262Phase 1

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15